Publicacións nas que colabora con J.M. Arbelo González (7)

2021

  1. A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: The SynapSES trial

    Journal of Parkinson's Disease, Vol. 11, Núm. 1, pp. 187-198

  2. Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease

    npj Parkinson's Disease, Vol. 7, Núm. 1

  3. Spanish expert consensus on the use of safinamide in Parkinson's disease

    Neurologia, Vol. 36, Núm. 9, pp. 666-672

2019

  1. Impact of disease duration in effectiveness of treatment with levodopa-carbidopa intestinal gel and factors leading to discontinuation

    Journal of Parkinson's Disease, Vol. 9, Núm. 1, pp. 173-182

2016

  1. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression

    BMC Neurology, Vol. 16, Núm. 1

  2. Erratum to: COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression [BMC Neurol. 16, (2015), 26] DOI: 10.1186/s12883-016-0548-9

    BMC Neurology

  3. Long-term effectiveness of levodopa-carbidopa intestinal gel in 177 Spanish patients with advanced Parkinson's disease

    Neurodegenerative disease management, Vol. 6, Núm. 4, pp. 289-298